InsidersTradesSigma
Track the RemeGen Co., Ltd. share price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Operating in the Health Care sector, RemeGen Co., Ltd. has published 53 public disclosures. Market capitalisation: €49.6bn. The latest transaction was filed on 24 April 2026 (Sale). Among the most active insiders: Lin Jian. The full history is openly available.
53
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€37m
53 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate RemeGen Co., Ltd. Buy (bullish), based on 15 analysts. Average price target: HK$115.63.
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,060 of 29,063 companies
54.6
score / 100
Value27
Quality82
FCF yld-0.3%
Earn yld1.5%
EV/EBITDA44.8x
ROE45%
Gross mgn87%
Net mgn22%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 April 2026
Declarations53 total
10,000 shares@ HK$90.07251.3% of flowShareXHKGHKEX:DA20260423E00706
20,000 shares@ HK$97.202.9% of flowShareXHKGHKEX:DA20260423E00726
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00682
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00764
10,000 shares@ HK$90.07251.3% of flowShareXHKGHKEX:DA20260423E00758
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00759
60,000 shares@ HK$85.007.7% of flowShareXHKGHKEX:DA20260423E00755
20,000 shares@ HK$97.202.9% of flowShareXHKGHKEX:DA20260423E00709
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00712
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00707
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00705
60,000 shares@ HK$86.007.7% of flowShareXHKGHKEX:DA20260423E00704
60,000 shares@ HK$85.007.7% of flowShareXHKGHKEX:DA20260423E00703
100,000 shares@ HK$108.49616.0% of flowShareXHKGHKEX:DA20260423E00701
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00729
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00722
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00724
25 of 53 declarations
Acerca de RemeGen Co., Ltd.
RemeGen Co., Ltd. es una empresa biofarmacéutica china centrada en la investigación y el desarrollo de tratamientos para el cáncer y otras enfermedades graves. Cotiza en la Bolsa de Hong Kong bajo el símbolo H Shares.